Archives
2026 New York Regional Symposium
The 2026 New York Cholangiocarcinoma Symposium is set to convene in NYC, drawing together leading experts, researchers, healthcare professionals, patients,…
2026 Birmingham Regional Symposium
The 2026 Birmingham Cholangiocarcinoma Symposium is set to convene in Birmingham, Alabama, drawing together leading experts, researchers, healthcare professionals, patients,…
2025 Houston Cholangiocarcinoma Symposium
The 2025 Houston Cholangiocarcinoma Symposium is set to convene in Houston, drawing together leading experts, researchers, healthcare professionals, patients, and…
2025-2026 Prospectus Catalog
For more information on our industry partnership programs, please visit our CCF Industry Partners webpage at curecca.org/industry-partners 202510 Development Partnership…
2025 Chicago Regional Symposium
The 2025 Chicago Cholangiocarcinoma Symposium is set to convene in Chicago, drawing together leading experts, researchers, healthcare professionals, patients, and…
2025 Epic Experience Camp
The Cholangiocarcinoma Foundation has an opportunity to sponsor a small group of patients to attend a free experience with the…
2025 Portland Cholangiocarcinoma Symposium
The 2025 Portland Cholangiocarcinoma Symposium will convene in Portland and draw together leading experts, researchers, healthcare professionals, patients, and advocates.…
2025 Los Angeles Cholangiocarcinoma Symposium
The 2025 Los Angeles Symposium, hosted with USC Norris Comprehensive Cancer Center, brings together leading experts, researchers, healthcare professionals, patients,…
2024 Houston Cholangiocarcinoma Symposium
The 2024 Houston Cholangiocarcinoma Symposium is set to convene in Houston, drawing together leading experts, researchers, healthcare professionals, patients, and…
2024 Chicago Cholangiocarcinoma Symposium
The 2024 Chicago Cholangiocarcinoma Symposium is set to convene in Chicago, drawing together leading experts, researchers, healthcare professionals, patients, and…
A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors
Study Name A Phase Ia/Ib Study of the Combination of the FGFR inhibitor Pemigatinib and the EGFR inhibitor Afatinib in Advanced Refractory Solid Tumors…
Peggy Newland
12/19/1967-9/22/2021 On September 22, 2021, a cherished daughter, sister, mother, and grandmother, lost a courageous battle with cancer ( a…